Margolis DM - Search Results

1

Selective HDAC inhibition for the disruption of latent HIV-1 infection.

Barton KM, Archin NM, Keedy KS, Espeseth AS, Zhang YL, Gale J, Wagner FF, Holson EB, Margolis DM. Barton KM, et al. Among authors: margolis dm. PLoS One. 2014 Aug 19;9(8):e102684. doi: 10.1371/journal.pone.0102684. eCollection 2014. PLoS One. 2014. PMID: 25136952 Free PMC article.

2

Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression.

Ylisastigui L, Archin NM, Lehrman G, Bosch RJ, Margolis DM. Ylisastigui L, et al. Among authors: margolis dm. AIDS. 2004 May 21;18(8):1101-8. doi: 10.1097/00002030-200405210-00003. AIDS. 2004. PMID: 15166525

3

Attacking HIV provirus: therapeutic strategies to disrupt persistent infection.

Margolis DM, Archin NM. Margolis DM, et al. Infect Disord Drug Targets. 2006 Dec;6(4):369-76. doi: 10.2174/187152606779025824. Infect Disord Drug Targets. 2006. PMID: 17168802 Review.

4

Eliminating persistent HIV infection: getting to the end of the rainbow.

Margolis DM, Archin NM. Margolis DM, et al. J Infect Dis. 2007 Jun 15;195(12):1734-6. doi: 10.1086/518254. Epub 2007 May 2. J Infect Dis. 2007. PMID: 17492587 No abstract available.

5

Confronting proviral HIV infection.

Margolis DM. Margolis DM. Curr HIV/AIDS Rep. 2007 May;4(2):60-4. doi: 10.1007/s11904-007-0009-6. Curr HIV/AIDS Rep. 2007. PMID: 17547826 Review.

6

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.

Jiang G, Espeseth A, Hazuda DJ, Margolis DM. Jiang G, et al. Among authors: margolis dm. J Virol. 2007 Oct;81(20):10914-23. doi: 10.1128/JVI.01208-07. Epub 2007 Aug 1. J Virol. 2007. PMID: 17670825 Free PMC article.

7

Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.

Choudhary SK, Archin NM, Margolis DM. Choudhary SK, et al. Among authors: margolis dm. J Infect Dis. 2008 Apr 15;197(8):1162-70. doi: 10.1086/529525. J Infect Dis. 2008. PMID: 18419522

8

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.

Archin NM, Eron JJ, Palmer S, Hartmann-Duff A, Martinson JA, Wiegand A, Bandarenko N, Schmitz JL, Bosch RJ, Landay AL, Coffin JM, Margolis DM. Archin NM, et al. Among authors: margolis dm. AIDS. 2008 Jun 19;22(10):1131-5. doi: 10.1097/QAD.0b013e3282fd6df4. AIDS. 2008. PMID: 18525258 Free PMC article.

9

Pharmaceutical approaches to eradication of persistent HIV infection.

Bowman MC, Archin NM, Margolis DM. Bowman MC, et al. Among authors: margolis dm. Expert Rev Mol Med. 2009 Feb 11;11:e6. doi: 10.1017/S1462399409000970. Expert Rev Mol Med. 2009. PMID: 19208267 Review.

10

Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid.

Archin NM, Espeseth A, Parker D, Cheema M, Hazuda D, Margolis DM. Archin NM, et al. Among authors: margolis dm. AIDS Res Hum Retroviruses. 2009 Feb;25(2):207-12. doi: 10.1089/aid.2008.0191. AIDS Res Hum Retroviruses. 2009. PMID: 19239360 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters